Koshinski Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.12M Buy
5,099
+316
+7% +$323K 0.33% 68
2026
Q1
$4.4M Sell
4,783
-59
-1% -$59.8K 0.27% 83
2025
Q4
$5.2M Buy
4,842
+57
+1% +$54.5K 0.34% 61
2025
Q3
$3.65M Buy
4,785
+112
+2% +$83.3K 0.25% 89
2025
Q2
$3.64M Buy
4,673
+391
+9% +$304K 0.28% 77
2025
Q1
$3.54M Buy
4,282
+23
+0.5% +$19.1K 0.3% 74
2024
Q4
$3.29B Sell
4,259
-17
-0.4% -$14.1K 0.28% 80
2024
Q3
$3.79M Sell
4,276
-354
-8% -$318K 0.33% 66
2024
Q2
$4.32M Buy
4,630
+117
+3% +$93.6K 0.4% 52
2024
Q1
$3.51M Buy
4,513
+965
+27% +$687K 0.36% 62
2023
Q4
$2.07M Sell
3,548
-747
-17% -$436K 0.31% 88
2023
Q3
$2.31M Buy
4,295
+151
+4% +$77.8K 0.27% 87
2023
Q2
$1.94M Sell
4,144
-796
-16% -$334K 0.21% 109
2023
Q1
$1.7M Sell
4,940
-107
-2% -$36.1K 0.17% 129
2022
Q4
$1.85M Sell
5,047
-17
-0.3% -$6.03K 0.18% 130
2022
Q3
$1.64M Sell
5,064
-264
-5% -$83.6K 0.2% 126
2022
Q2
$1.73M Buy
5,328
+479
+10% +$144K 0.17% 139
2022
Q1
$1.39M Buy
4,849
+38
+0.8% +$9.78K 0.11% 187
2021
Q4
$1.33M Buy
4,811
+54
+1% +$13.7K 0.11% 200
2021
Q3
$1.1M Buy
4,757
+936
+24% +$231K 0.1% 232
2021
Q2
$877K Sell
3,821
-1,118
-23% -$225K 0.11% 210
2021
Q1
$923K Buy
4,939
+1,862
+61% +$364K 0.1% 242
2020
Q4
$520K Buy
3,077
+157
+5% +$23.4K 0.07% 309
2020
Q3
$451 Sell
2,920
-68
-2% -$10.5K 0.06% 313
2020
Q2
$491K Sell
2,988
-73
-2% -$11.2K 0.08% 280
2020
Q1
$425K Buy
3,061
+22
+0.7% +$3.02K 0.09% 267
2019
Q4
$399K Buy
3,039
+1,222
+67% +$142K 0.07% 353
2019
Q3
$203K Hold
1,817
0.14% 146
2019
Q2
$201K Sell
1,817
-330
-15% -$38.9K 0.08% 260
2019
Q1
$279 Sell
2,147
-3,349
-61% -$407K 0.07% 301
2018
Q4
$636K Sell
5,496
-4,334
-44% -$484K 0.16% 184
2018
Q3
$1.05M Buy
9,830
+4,417
+82% +$442K 0.15% 196
2018
Q2
$462K Sell
5,413
-319
-6% -$26.2K 0.14% 221
2018
Q1
$443K Sell
5,732
-1,912
-25% -$154K 0.14% 227
2017
Q4
$646K Buy
7,644
+1,297
+20% +$110K 0.16% 215
2017
Q3
$543K Buy
6,347
+132
+2% +$10.8K 0.18% 188
2017
Q2
$511K Buy
6,215
+283
+5% +$23.1K 0.19% 186
2017
Q1
$499K Buy
5,932
+2,492
+72% +$200K 0.2% 155
2016
Q4
$253K Sell
3,440
-410
-11% -$30.5K 0.13% 236
2016
Q3
$309K Buy
3,850
+78
+2% +$6.24K 0.15% 209
2016
Q2
$297K Buy
3,772
+1,400
+59% +$105K 0.16% 196
2016
Q1
$248K Buy
+2,372
New +$179K 0.16% 186

Other funds holding LLY

Koshinski Asset Management's LLY Position: Q2 2026 in Review

Koshinski Asset Management increased its Eli Lilly (LLY) stake by 6.6% in Q2 2026, buying an estimated $323K and bringing the position to 5,099 shares worth $6.12M. The position accounts for 0.33% of the portfolio, ranked #68.

Koshinski Asset Management first reported a position in LLY in Q1 2016 and has held it in 42 quarters since. The position peaked at $3.29B in Q4 2024. 1,692 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Koshinski Asset Management held 5,099 shares of Eli Lilly worth $6.12M as of Q2 2026.
  • Koshinski Asset Management bought 316 Eli Lilly shares in Q2 2026, an estimated $323K.
  • Eli Lilly made up 0.33% of Koshinski Asset Management's portfolio in Q2 2026, its #68 holding.
  • Koshinski Asset Management first reported a position in Eli Lilly in Q1 2016 and has held it in 42 quarters since.
  • Koshinski Asset Management's Eli Lilly position peaked at $3.29B in Q4 2024.
  • 1,692 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Koshinski Asset Management's 13F filing for Q2 2026, filed 27 Jul 2026.